Connect with us

Technology

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial – The Lancet

In community-treated patients including those without a mandatory diagnostic test,the effect of colchicine on COVID-19-related clinical events was not statistically…

Published

on

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.
Privacy Policy   Terms and Conditions

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending